아카디아 파마슈티컬스(ACADIA Pharmaceuticals Inc.)
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership3,236 shares
Latest Disclosed Value $ 69,800
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 14.30% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 3,236 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $69,801 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 3,776 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -14.30% during the quarter. The current value of the position is $70,286 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP ACADIA Pharmaceuticals EC US0042251084 3,236 -540 -14.30 70 11.29 0.7757
2025-05-29 2025-03-31 NP ACADIA Pharmaceuticals EC US0042251084 3,776 -60 -1.56 63 -11.43 0.6663
2025-03-03 2024-12-31 NP ACADIA Pharmaceuticals EC US0042251084 3,836 -634 -14.18 70 2.94 0.7057
2024-11-29 2024-09-30 NP ACADIA Pharmaceuticals EC US0042251084 4,470 -142 -3.08 69 -8.11 0.6227
2024-08-29 2024-06-30 NP ACADIA Pharmaceuticals EC US0042251084 4,612 366 8.62 75 -5.13 0.6833
2024-05-30 2024-03-31 NP ACADIA Pharmaceuticals EC US0042251084 4,246 64 1.53 79 -40.00 0.6658
2024-02-29 2023-12-31 NP ACADIA Pharmaceuticals EC US0042251084 4,182 -128 -2.97 131 46.07 1.0732
2023-11-29 2023-09-30 NP ACADIA Pharmaceuticals EC US0042251084 4,310 -219 -4.84 90 -17.59 0.7777
2023-08-28 2023-06-30 NP ACADIA Pharmaceuticals EC US0042251084 4,529 -430 -8.67 108 16.13 0.8560
2023-05-30 2023-03-31 NP ACADIA Pharmaceuticals EC US0042251084 4,959 -4,224 -46.00 93 -38.82 0.7069
2021-11-29 2021-09-30 NP ACADIA Pharmaceuticals EC US0042251084 9,183 1,715 22.96 153 -16.48 0.6412
2021-08-27 2021-06-30 NP ACADIA Pharmaceuticals EC US0042251084 7,468 -73 -0.97 182 -6.19 0.7629
2021-05-27 2021-03-31 NP ACADIA Pharmaceuticals EC US0042251084 7,541 1,407 22.94 195 -40.67 0.8755
2021-03-01 2020-12-31 NP ACADIA Pharmaceuticals EC US0042251084 6,134 -2,194 -26.34 328 -4.66 1.3355
2020-11-25 2020-09-30 NP ACADIA Pharmaceuticals EC US0042251084 8,328 785 10.41 344 -6.03 1.4338
2020-08-27 2020-06-30 NP ACADIA Pharmaceuticals EC US0042251084 7,543 -166 -2.15 366 12.31 1.4734
2020-06-01 2020-03-31 NP ACADIA Pharmaceuticals EC US0042251084 7,709 -491 -5.99 326 -7.14 1.9936
2020-03-02 2019-12-31 NP ACADIA Pharmaceuticals EC US0042251084 8,200 353 4.50 351 24.11 1.6237
2019-11-27 2019-09-30 NP ACADIA Pharmaceuticals EC US0042251084 7,847 7,847 282 1.4982
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.